HANGZHOU, China, March 17, 2025 /PRNewswire/ -- Chance Pharmaceuticals ("Chance Pharma ... innovative dry powder inhalation (DPI) therapies. The company's pipeline is supported by two core ...

Azurity Pharmaceuticals CEO Ronald Scarboro stated: “We are excited to welcome Covis Pharma to Azurity. The efforts of colleagues at both companies, their devotion to overlooked patients and our ...

SUN Pharmaceutical Medicare Limited is an Indian Non-Government Company. It's a public company and is classified as'company limited by shares'. Company's authorized capital stands at Rs 25.0 lakhs and ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

BridgeBio Pharma, Inc. (NASDAQ:BBIO), a biotechnology company with ... hinder the drug’s market penetration and revenue growth. BridgeBio’s diverse and innovative pipeline presents significant ...

BridgeBio Pharma, Inc. (NASDAQ ... BridgeBio’s diverse and innovative pipeline presents significant opportunities for long-term growth beyond Attruby. The company’s focus on genetic diseases ...

UK-based Alliance Pharma has agreed to a final increased cash offer from asset management company DBAY Advisors, valuing the former at approximately £362m ($467.5m). The offer, made through a newly ...

Discover how modern construction tech is shaping the future.The construction industry is embracing cutting-edge technologies that are revolutionizing the way projects are planned, executed ...

Laurus Labs slumped 11.6%, Aurobindo declined 2%, Cipla fell 1.1% and Strides dropped 5%. Other pharma shares also declined with 19 out of 20 stocks on the Nifty Pharma index ending lower. The pharma ...